Test Price
2,800 AED✅ Home Collection Available
EEF1A2 Gene Early Infantile Epileptic Encephalopathy Type 33 Genetic Test | 2800 AED | 2026 DHA Guidelines
تحليل جين EEF1A2 لاعتلال الدماغ الصرعي الطفولي المبكر من النوع 33 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
99.9% Diagnostic Sensitivity for EEF1A2 mutations via ISO 9001:2015 Certified NGS. Results correlated with 2026 DHA/MOHAP reference databases. دقة تشخيصية بنسبة 99.9% عبر مختبر معتمد آيزو، وعينة منزلية مشمولة بالسعر.
ISO‑compliant cold‑chain transport, VIP mobile phlebotomy 8 AM‑11 PM, and 2800 AED all‑inclusive pricing. خدمة سحب الدم المنزلية بتقنية سلسلة التبريد، وسعر شامل 2800 درهم.
One-on-one post‑test tele‑genetic counseling and direct insurance billing verification via WhatsApp +971 54 548 8731.
Overview – Why This Test Matters
This next-generation sequencing test screens the entire coding region of the EEF1A2 gene, pinpointing pathogenic variants responsible for Early Infantile Epileptic Encephalopathy Type 33 (EIEE33), a severe neonatal/early-infant seizure disorder. Rapid molecular diagnosis enables avoidance of empirical therapies and directs precision management, including eligibility for emerging targeted treatments.
يكشف تحليل الجين EEF1A2 عن الطفرات المسببة لاعتلال الدماغ الصرعي الطفولي المبكر من النوع 33، مما يوجه العلاج الدقيق ويحسن النتائج السريرية.
| Feature | Our EEF1A2 NGS Test | Closest Alternative (Sanger / Panel) |
|---|---|---|
| Precision | Full‑gene sequencing with 100× mean depth, detects SNVs, indels, CNVs | Targeted Sanger of selected exons only; limited CNV detection |
| Methodology | Next‑Generation Sequencing (NGS) – ISO 9001:2015 validated | Sanger Sequencing |
| Turnaround Time | 3–4 weeks with clinical report | 4–6 weeks (fragment‑based) |
Physician Insight & Safety Protocol
A Note from Dr. Prabhakar Reddy (DHA License: 61713011) — This NGS assay is a transformative diagnostic tool for infants with unexplained, treatment‑resistant seizures. However, DNA findings must always be integrated with EEG, neuroimaging, and detailed clinical history to formulate a holistic care plan. Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Known acquired structural brain injury (e.g., hypoxic‑ischemic encephalopathy from acute birth trauma) — alternative testing may be more appropriate.
- Exclusion: Genetic testing of asymptomatic minors without parental/legal guardian consent, as per UAE CDS Law 2026.
- Seek Emergency Care Immediately If: Seizure lasts >5 minutes, infant stops breathing, or exhibits unresponsiveness after a convulsion.
Patient FAQ & Clinical Guidance
1. What is the EEF1A2 gene test, and how can it help my child with unexplained seizures?
This DNA test identifies mutations in the EEF1A2 gene causing early infantile epileptic encephalopathy type 33, guiding precise treatment and prognosis for affected infants. It can prevent invasive investigations and accelerate targeted therapies such as ketogenic diet or anti‑seizure medications suited to the genetic subtype. يحدد هذا الاختبار الطفرات في جين EEF1A2 المسببة لاعتلال الدماغ الصرعي الطفولي المبكر، مما يوجه العلاج الدقيق ويحسن المآل.
2. How is the sample collected, and is home collection available in the UAE?
We offer hospital-grade home collection of a small blood sample, buccal swab, or extracted DNA by a certified phlebotomist, with cold-chain transport ensuring sample stability. Appointments are available 8 AM‑11 PM across all emirates; minimal preparation — no fasting required. نوفر خدمة سحب الدم المنزلي لعينة صغيرة أو مسحة فموية بواسطة فني معتمد، مع نقل بسلسلة تبريد لضمان الجودة.
3. How long do results take, and will I receive genetic counseling?
Results are delivered within 3-4 weeks, and you will receive a comprehensive post‑ genetic counseling session to interpret findings and plan next steps. This includes a detailed family pedigree chart and guidance on recurrence risk for future pregnancies. تصدر النتائج خلال 3-4 أسابيع وستحصل على جلسة استشارة وراثية شاملة لتفسير النتائج والتخطيط للخطوات التالية.
UAE Regulatory Compliance: Conducted under Federal Decree‑Law No. 41 of 2024, Art. 87; UAE Child Data Safety Law (CDS 2026) for minors; UAE Personal Data Protection Law (PDPL). ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453. Direct billing & support: +971545488731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians